NutriBand (NTRB) Cost of Revenue (2018 - 2026)
NutriBand's (NTRB) quarterly Cost of Revenue came in at $311768.0 in Q1 2026, down 12.53% year-on-year from $356435.0 in Q1 2025, and up 12.33% quarter-over-quarter from $277553.0 in Q4 2025.
NutriBand (NTRB) Cost of Revenue (2018 - 2026) Analysis & Trends
NutriBand has disclosed Cost of Revenue across 9 years of filings, most recently posting $311768.0 for Q1 2026.
- Cost of Revenue for Q1 2026 came in at $311768.0, down 12.53% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.5 million (up 5.31% YoY), and the FY2026 annual result was $1.5 million, up 5.31% from the prior year.
- Cost of Revenue came in at $311768.0 for Q1 2026 at NutriBand, up from $277553.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $465571.0 in Q3 2025 to a low of $243746.0 in Q2 2024.
- The 5-year median for Cost of Revenue is $341272.0 (2024), against an average of $336442.1.
- Peak annual rise in Cost of Revenue reached 70.44% in 2025, while the deepest fall reached 38.97% in 2025.
- NutriBand's Cost of Revenue stood at $349272.0 in 2022, then slipped by 23.01% to $268920.0 in 2023, then surged by 69.11% to $454767.0 in 2024, then slumped by 38.97% to $277553.0 in 2025, then climbed by 12.33% to $311768.0 in 2026.
- The last three Cost of Revenue figures came in at $311768.0 (Q1 2026), $277553.0 (Q4 2025), and $465571.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 2.05 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 311,768.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 311,768.00 |
| Jan 31, 2026 | 311,768.00 |
| Oct 31, 2025 | 277,553.00 |
| Oct 31, 2025 | 277,553.00 |
| Jul 31, 2025 | 465,571.00 |
| Jul 31, 2025 | 465,571.00 |
| Apr 30, 2025 | 415,451.00 |
| Apr 30, 2025 | 415,451.00 |
| Jan 31, 2025 | 356,435.00 |
| Jan 31, 2025 | 356,435.00 |
| Oct 31, 2024 | 454,767.00 |
| Oct 31, 2024 | 454,767.00 |
| Jul 31, 2024 | 341,272.00 |
| Jul 31, 2024 | 341,272.00 |
| Apr 30, 2024 | 243,746.00 |
| Apr 30, 2024 | 243,746.00 |
| Jan 31, 2024 | 343,385.00 |
| Jan 31, 2024 | 343,385.00 |
| Oct 31, 2023 | 268,920.00 |
| Oct 31, 2023 | 268,920.00 |